Product NDC: | 50419-208 |
Proprietary Name: | Xofigo |
Non Proprietary Name: | Radium Ra 223 dichloride |
Active Ingredient(s): | 27 uCi/mL & nbsp; Radium Ra 223 dichloride |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 50419-208 |
Labeler Name: | Bayer HealthCare Pharmaceuticals Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA203971 |
Marketing Category: | NDA |
Start Marketing Date: | 20130520 |
Package NDC: | 50419-208-01 |
Package Description: | 6 mL in 1 VIAL, SINGLE-DOSE (50419-208-01) |
NDC Code | 50419-208-01 |
Proprietary Name | Xofigo |
Package Description | 6 mL in 1 VIAL, SINGLE-DOSE (50419-208-01) |
Product NDC | 50419-208 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Radium Ra 223 dichloride |
Dosage Form Name | INJECTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 20130520 |
Marketing Category Name | NDA |
Labeler Name | Bayer HealthCare Pharmaceuticals Inc. |
Substance Name | RADIUM CHLORIDE RA-223 |
Strength Number | 27 |
Strength Unit | uCi/mL |
Pharmaceutical Classes |